AAPL327.17-5.85 (-1.76%) ▼|ABBV260.57-1.02 (-0.39%) ▼|ABT97.71-1.12 (-1.13%) ▼|ACN215.99+32.62 (+17.79%) ▲|ADBE238.15-1.80 (-0.75%) ▼|AMAT524.34+12.96 (+2.53%) ▲|AMD611.70-0.07 (-0.01%) ▼|AMGN411.82-9.69 (-2.30%) ▼|AMT162.27-1.42 (-0.87%) ▼|AMZN246.60-2.55 (-1.02%) ▼|AVGO346.77-4.42 (-1.26%) ▼|AXP299.25-4.85 (-1.59%) ▼|BA187.66+1.61 (+0.87%) ▲|BAC53.28-1.16 (-2.12%) ▼|BKNG160.87-2.04 (-1.25%) ▼|BLK1,060.01+1.72 (+0.16%) ▲|BMY61.61-0.80 (-1.27%) ▼|BNY142.38-2.25 (-1.56%) ▼|BRK-B498.66+0.71 (+0.14%) ▲|C124.88-4.60 (-3.55%) ▼|CAT816.26+5.47 (+0.67%) ▲|CL84.64-0.68 (-0.80%) ▼|CMCSA21.57-0.19 (-0.87%) ▼|COF191.42-1.65 (-0.85%) ▼|COP127.05+1.90 (+1.52%) ▲|COST921.34+11.00 (+1.21%) ▲|CRM231.09+1.52 (+0.66%) ▲|CSCO108.17+0.54 (+0.50%) ▲|CVS85.02-0.67 (-0.78%) ▼|CVX206.47+2.26 (+1.11%) ▲|DE661.04-10.51 (-1.57%) ▼|DHR216.15-5.41 (-2.44%) ▼|DIS101.77-3.13 (-2.98%) ▼|DUK113.45-0.56 (-0.49%) ▼|EMR157.02+1.92 (+1.23%) ▲|FDX286.68+1.59 (+0.56%) ▲|GD333.57+1.74 (+0.52%) ▲|GE312.12-0.18 (-0.06%) ▼|GEV966.63+16.14 (+1.70%) ▲|GILD147.82-1.23 (-0.83%) ▼|GM77.41+0.41 (+0.53%) ▲|GOOG337.08-3.66 (-1.07%) ▼|GOOGL340.16-3.93 (-1.14%) ▼|GS887.85-12.51 (-1.39%) ▼|HD279.64-4.86 (-1.71%) ▼|HON213.04+2.10 (+0.99%) ▲|IBM224.71+4.78 (+2.17%) ▲|INTC119.57-0.66 (-0.55%) ▼|INTU277.73+2.02 (+0.73%) ▲|ISRG401.89-4.75 (-1.17%) ▼|JNJ261.78-2.97 (-1.12%) ▼|JPM328.64-2.19 (-0.66%) ▼|KO86.29+0.21 (+0.24%) ▲|LIN463.35-11.30 (-2.38%) ▼|LLY1,146.55-10.53 (-0.91%) ▼|LMT507.31-1.94 (-0.38%) ▼|LOW180.58-3.71 (-2.01%) ▼|LRCX333.62+5.11 (+1.56%) ▲|MA549.13-2.34 (-0.42%) ▼|MCD230.83-0.11 (-0.05%) ▼|MDLZ57.87+0.05 (+0.09%) ▲|MDT85.95-0.34 (-0.39%) ▼|META728.30+3.12 (+0.43%) ▲|MMM163.24-0.92 (-0.56%) ▼|MO66.94-0.40 (-0.59%) ▼|MRK144.53-0.78 (-0.54%) ▼|MS184.16-3.92 (-2.08%) ▼|MSFT513.30+0.40 (+0.08%) ▲|MU1,051.17-13.94 (-1.31%) ▼|NEE75.73-0.01 (-0.01%) ▼|NFLX68.08-1.51 (-2.16%) ▼|NKE35.86+0.46 (+1.29%) ▲|NOW135.89+1.88 (+1.40%) ▲|NVDA229.22+0.84 (+0.37%) ▲|ORCL135.72-1.59 (-1.15%) ▼|PEP126.23-0.49 (-0.39%) ▼|PFE28.29-0.23 (-0.81%) ▼|PG143.93-1.35 (-0.93%) ▼|PLTR188.06+1.01 (+0.54%) ▲|PM187.83-2.99 (-1.57%) ▼|QCOM183.82-0.22 (-0.12%) ▼|RTX185.79+0.14 (+0.08%) ▲|SBUX94.39+0.43 (+0.45%) ▲|SCHW97.79+0.05 (+0.05%) ▲|SO83.11+0.22 (+0.27%) ▲|SPG199.63-1.13 (-0.56%) ▼|T24.38-0.03 (-0.10%) ▼|TMO664.09-10.97 (-1.62%) ▼|TMUS162.19-0.89 (-0.55%) ▼|TSLA357.06+2.25 (+0.63%) ▲|TXN280.01-0.08 (-0.03%) ▼|UBER67.63-0.88 (-1.28%) ▼|UNH363.33-3.75 (-1.02%) ▼|UNP271.21-0.92 (-0.34%) ▼|UPS94.28+0.84 (+0.89%) ▲|USB56.58-1.18 (-2.04%) ▼|V359.13-0.20 (-0.06%) ▼|VZ45.92+0.05 (+0.12%) ▲|WFC78.98-1.07 (-1.34%) ▼|WMT104.91+0.99 (+0.95%) ▲|XOM163.71+0.96 (+0.59%) ▲|AAPL327.17-5.85 (-1.76%) ▼|ABBV260.57-1.02 (-0.39%) ▼|ABT97.71-1.12 (-1.13%) ▼|ACN215.99+32.62 (+17.79%) ▲|ADBE238.15-1.80 (-0.75%) ▼|AMAT524.34+12.96 (+2.53%) ▲|AMD611.70-0.07 (-0.01%) ▼|AMGN411.82-9.69 (-2.30%) ▼|AMT162.27-1.42 (-0.87%) ▼|AMZN246.60-2.55 (-1.02%) ▼|AVGO346.77-4.42 (-1.26%) ▼|AXP299.25-4.85 (-1.59%) ▼|BA187.66+1.61 (+0.87%) ▲|BAC53.28-1.16 (-2.12%) ▼|BKNG160.87-2.04 (-1.25%) ▼|BLK1,060.01+1.72 (+0.16%) ▲|BMY61.61-0.80 (-1.27%) ▼|BNY142.38-2.25 (-1.56%) ▼|BRK-B498.66+0.71 (+0.14%) ▲|C124.88-4.60 (-3.55%) ▼|CAT816.26+5.47 (+0.67%) ▲|CL84.64-0.68 (-0.80%) ▼|CMCSA21.57-0.19 (-0.87%) ▼|COF191.42-1.65 (-0.85%) ▼|COP127.05+1.90 (+1.52%) ▲|COST921.34+11.00 (+1.21%) ▲|CRM231.09+1.52 (+0.66%) ▲|CSCO108.17+0.54 (+0.50%) ▲|CVS85.02-0.67 (-0.78%) ▼|CVX206.47+2.26 (+1.11%) ▲|DE661.04-10.51 (-1.57%) ▼|DHR216.15-5.41 (-2.44%) ▼|DIS101.77-3.13 (-2.98%) ▼|DUK113.45-0.56 (-0.49%) ▼|EMR157.02+1.92 (+1.23%) ▲|FDX286.68+1.59 (+0.56%) ▲|GD333.57+1.74 (+0.52%) ▲|GE312.12-0.18 (-0.06%) ▼|GEV966.63+16.14 (+1.70%) ▲|GILD147.82-1.23 (-0.83%) ▼|GM77.41+0.41 (+0.53%) ▲|GOOG337.08-3.66 (-1.07%) ▼|GOOGL340.16-3.93 (-1.14%) ▼|GS887.85-12.51 (-1.39%) ▼|HD279.64-4.86 (-1.71%) ▼|HON213.04+2.10 (+0.99%) ▲|IBM224.71+4.78 (+2.17%) ▲|INTC119.57-0.66 (-0.55%) ▼|INTU277.73+2.02 (+0.73%) ▲|ISRG401.89-4.75 (-1.17%) ▼|JNJ261.78-2.97 (-1.12%) ▼|JPM328.64-2.19 (-0.66%) ▼|KO86.29+0.21 (+0.24%) ▲|LIN463.35-11.30 (-2.38%) ▼|LLY1,146.55-10.53 (-0.91%) ▼|LMT507.31-1.94 (-0.38%) ▼|LOW180.58-3.71 (-2.01%) ▼|LRCX333.62+5.11 (+1.56%) ▲|MA549.13-2.34 (-0.42%) ▼|MCD230.83-0.11 (-0.05%) ▼|MDLZ57.87+0.05 (+0.09%) ▲|MDT85.95-0.34 (-0.39%) ▼|META728.30+3.12 (+0.43%) ▲|MMM163.24-0.92 (-0.56%) ▼|MO66.94-0.40 (-0.59%) ▼|MRK144.53-0.78 (-0.54%) ▼|MS184.16-3.92 (-2.08%) ▼|MSFT513.30+0.40 (+0.08%) ▲|MU1,051.17-13.94 (-1.31%) ▼|NEE75.73-0.01 (-0.01%) ▼|NFLX68.08-1.51 (-2.16%) ▼|NKE35.86+0.46 (+1.29%) ▲|NOW135.89+1.88 (+1.40%) ▲|NVDA229.22+0.84 (+0.37%) ▲|ORCL135.72-1.59 (-1.15%) ▼|PEP126.23-0.49 (-0.39%) ▼|PFE28.29-0.23 (-0.81%) ▼|PG143.93-1.35 (-0.93%) ▼|PLTR188.06+1.01 (+0.54%) ▲|PM187.83-2.99 (-1.57%) ▼|QCOM183.82-0.22 (-0.12%) ▼|RTX185.79+0.14 (+0.08%) ▲|SBUX94.39+0.43 (+0.45%) ▲|SCHW97.79+0.05 (+0.05%) ▲|SO83.11+0.22 (+0.27%) ▲|SPG199.63-1.13 (-0.56%) ▼|T24.38-0.03 (-0.10%) ▼|TMO664.09-10.97 (-1.62%) ▼|TMUS162.19-0.89 (-0.55%) ▼|TSLA357.06+2.25 (+0.63%) ▲|TXN280.01-0.08 (-0.03%) ▼|UBER67.63-0.88 (-1.28%) ▼|UNH363.33-3.75 (-1.02%) ▼|UNP271.21-0.92 (-0.34%) ▼|UPS94.28+0.84 (+0.89%) ▲|USB56.58-1.18 (-2.04%) ▼|V359.13-0.20 (-0.06%) ▼|VZ45.92+0.05 (+0.12%) ▲|WFC78.98-1.07 (-1.34%) ▼|WMT104.91+0.99 (+0.95%) ▲|XOM163.71+0.96 (+0.59%) ▲|
22 C
New York
Thursday, October 1, 2026

Tag: 1

newssourceFORcompanyinformationcontent1releasesmarket

Insmed Announces Pricing of $750 Million Public Offering of Common Stock

BRIDGEWATER, N.J., June 11, 2025 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to...

Mesoblast Maintains Momentum With FDA on Accelerated Approval Pathway for Revascor® in Ischemic Heart Failure and Label Extension for Ryoncil® in Adults With GvHD

NEW YORK, June 11, 2025 (GLOBE NEWSWIRE) -- Mesoblast (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today provided an update on continued momentum with United States Food and Drug Administration (FDA) regarding both accelerated approval pathway for Revascor® (rexlemestrocel-L) in the treatment of patients with ischemic chronic heart failure with reduced ejection fraction (HFrEF) and inflammation, and label extension for Ryoncil® (remestemcel-L-rknd) in adults with steroid refractory acute graft versus host disease (SR-aGvHD).

Sony Music Labels Acquires Full Rights of Globally Beloved “Spookiz” and Launches Character Business

― Leveraging Expertise Cultivated in the Music Business to Create New Value ― TOKYO, June 11, 2025 /PRNewswire/ -- Sony Music Labels Inc. (Headquarters: Chiyoda-ku, Tokyo,...

Montfort Capital Announces First Quarter 2025 Financial Results and CFO Transition

TORONTO, June 11, 2025 /CNW/ - Montfort Capital Corp. ("Montfort" or the "Company") (TSXV: MONT), today announced financial results for the three months ended...

United States Presidential Culinary Museum® Celebrates America 250 with Launch of “The Washington’s Famous Syllabub Drink”

GROVER, N.C., June 11, 2025 /PRNewswire/ -- In honor of the Semiquincentennial—America's 250th anniversary of independence—the United States Presidential Culinary Museum® is continuing to...

ROSEN, A LONGSTANDING LAW FIRM, Encourages Organon & Co. Investors to Secure Counsel Before Important Deadline in Securities Class Action – OGN

NEW YORK, June 11, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Organon & Co. (NYSE: OGN) between October 31, 2024 and April 30, 2025, both dates inclusive (the “Class Period”), of the important July 22, 2025 lead plaintiff deadline.

ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Avis Budget Group, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action –...

NEW YORK, June 11, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Avis Budget Group, Inc. (NASDAQ: CAR) between February 16, 2024 and February 10, 2025, both dates inclusive (the “Class Period”), of the important June 24, 2025 lead plaintiff deadline.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors It Has Filed a Complaint to Recover Losses Suffered by Purchasers of Rocket Pharmaceuticals, Inc. Securities...

NEW YORK, June 11, 2025 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi & Korsinsky, LLP:

CODI INVESTOR ALERT: Kirby McInerney LLP Notifies Compass Group Diversified Holdings, LLC Investors of Upcoming Lead Plaintiff Deadline in Class Action Lawsuit

NEW YORK, June 11, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors of the July 8, 2025, deadline to seek the role of lead plaintiff in a federal securities class action filed on behalf of investors who acquired Compass Group Diversified Holdings, LLC (“Compass” or the “Company”) (NYSE:CODI) securities during the period from May 1, 2024, through May 7, 2025 (“the Class Period”).

Planet 13 Announces Results of Annual General Meeting

LAS VEGAS, June 11, 2025 (GLOBE NEWSWIRE) -- Planet 13 Holdings Inc. (CSE: PLTH) (OTCQX: PLNH) (“Planet 13” or the “Company”), a leading vertically-integrated multi-state cannabis company, today announced the following results for each item of business considered at Planet 13’s Annual General Meeting of Stockholders held on Tuesday, June 10, 2025.

EGBN Investor News: If You Have Suffered Losses in Eagle Bancorp, Inc. (NASDAQ: EGBN), You Are Encouraged to Contact The Rosen Law Firm About...

NEW YORK, June 11, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Eagle Bancorp, Inc. (NASDAQ: EGBN) resulting from allegations that Eagle Bancorp may have issued materially misleading business information to the investing public.

ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Civitas Resources, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – CIVI

NEW YORK, June 11, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Civitas Resources, Inc. (NYSE: CIVI) between February 27, 2024 and February 24, 2025, both dates inclusive (the “Class Period”), of the important July 1, 2025 lead plaintiff deadline.

ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages PepGen Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – PEPG

NEW YORK, June 11, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of PepGen Inc. (NASDAQ: PEPG) between March 7, 2024 and March 3, 2025, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 8, 2025.

Zip Codes and Credit Scores: Why Your Address and FICO Score May Be Driving Up Your Car Insurance

New data reveals that your ZIP code can increase car insurance costs by 20–40%, while a poor credit score may lead to a shocking...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTags1

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers